Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record for NCT04042701 is displayed, describing a phase 1b trial of trastuzumab deruxtecan with pembrolizumab for advanced breast cancer or non-small cell lung cancer. It includes participant eligibility and locations, study arms and outcome measures, record dates, and individual participant data-sharing information.
    Difference
    75%
    Check dated 2026-11-11T01:58:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:20:55.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH website-transition notice appeared above the 403 error page, and the site revision was updated.
    Difference
    1%
    Check dated 2026-10-21T00:25:18.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:38:22.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - The page now displays a 403 Forbidden error page with a 403 title, replacing the study record content with an access-denied message and a Home link. - This reflects an access restriction rather than changes to the study data or site layout.
    Difference
    0.5%
    Check dated 2026-09-30T00:43:21.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study record page now returns a 403 Forbidden page instead of showing the study details. The header and footer remain visible, but the main content is blocked, indicating the record is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-23T00:31:30.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.